Skip to main content
. 2014 Aug 28;9(8):e105905. doi: 10.1371/journal.pone.0105905

Table 3. Comparisons of SUVmax according to tumor characteristics.

Characteristics Mean SUVmax±SD P-valuea
Age, years 0.224
>35 (n = 27) 3.63±2.31
≤35 (n = 278) 4.43±3.28
Tumor size <0.001
≤2 cm (n = 174) 4.72±2.60
>2 cm (n = 131) 2.92±1.94
Lymph node status 0.011
Negative (n = 201) 3.44±2.36
Positive (n = 104) 4.18±2.41
Estrogen receptor status 0.928
Positive (n = 277) 3.69±2.43
Negative (n = 28) 3.74±2.33
Progesterone receptor status 0.394
Positive (n = 266) 3.74±2.47
Negative (n = 39) 3.43±2.00
HER2 <0.001
Negative (n = 258) 3.44±2.33
Positive (n = 47) 5.12±2.40
Ki67 0.011
<14% (n = 272) 3.57±2.35
≥14% (n = 33) 4.70±2.76
Histologic grade b <0.001
1 and 2 (n = 246) 5.85±2.84
3 (n = 26) 3.58±2.27
Subtype <0.001
Luminal A (n = 223) 3.22±2.15
Luminal B (n = 82) 4.98±2.64

HER2, human epidermal growth factor receptor-2.

a

Student’s t-tests.

b

Data with missing values.